203 related articles for article (PubMed ID: 10470285)
21. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
22. Anti-inflammatory and anti-oxidative effects of the green tea polyphenol epigallocatechin gallate in human corneal epithelial cells.
Cavet ME; Harrington KL; Vollmer TR; Ward KW; Zhang JZ
Mol Vis; 2011 Feb; 17():533-42. PubMed ID: 21364905
[TBL] [Abstract][Full Text] [Related]
23. Suppression of extracellular signals and cell proliferation by the black tea polyphenol, theaflavin-3,3'-digallate.
Liang YC; Chen YC; Lin YL; Lin-Shiau SY; Ho CT; Lin JK
Carcinogenesis; 1999 Apr; 20(4):733-6. PubMed ID: 10223207
[TBL] [Abstract][Full Text] [Related]
24. Green tea polyphenols: biology and therapeutic implications in cancer.
Shankar S; Ganapathy S; Srivastava RK
Front Biosci; 2007 Sep; 12():4881-99. PubMed ID: 17569617
[TBL] [Abstract][Full Text] [Related]
25. Review: green tea polyphenols in chemoprevention of prostate cancer: preclinical and clinical studies.
Khan N; Adhami VM; Mukhtar H
Nutr Cancer; 2009; 61(6):836-41. PubMed ID: 20155624
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea Constituent (-)-epigallocatechin-3-gallate.
Afaq F; Adhami VM; Ahmad N; Mukhtar H
Oncogene; 2003 Feb; 22(7):1035-44. PubMed ID: 12592390
[TBL] [Abstract][Full Text] [Related]
27. Green tea phenolics inhibit butyrate-induced differentiation of colon cancer cells by interacting with monocarboxylate transporter 1.
Sánchez-Tena S; Vizán P; Dudeja PK; Centelles JJ; Cascante M
Biochim Biophys Acta; 2013 Dec; 1832(12):2264-70. PubMed ID: 23994611
[TBL] [Abstract][Full Text] [Related]
28. Anticarcinogenic activity of green tea polyphenols.
Komori A; Yatsunami J; Okabe S; Abe S; Hara K; Suganuma M; Kim SJ; Fujiki H
Jpn J Clin Oncol; 1993 Jun; 23(3):186-90. PubMed ID: 8350491
[TBL] [Abstract][Full Text] [Related]
29. Multitargeted therapy of cancer by green tea polyphenols.
Khan N; Mukhtar H
Cancer Lett; 2008 Oct; 269(2):269-80. PubMed ID: 18501505
[TBL] [Abstract][Full Text] [Related]
30. Methylation suppresses the proteasome-inhibitory function of green tea polyphenols.
Landis-Piwowar KR; Wan SB; Wiegand RA; Kuhn DJ; Chan TH; Dou QP
J Cell Physiol; 2007 Oct; 213(1):252-60. PubMed ID: 17477351
[TBL] [Abstract][Full Text] [Related]
31. Green tea catechins (EGCG and EGC) have modulating effects on the activity of doxorubicin in drug-resistant cell lines.
Stammler G; Volm M
Anticancer Drugs; 1997 Mar; 8(3):265-8. PubMed ID: 9095331
[TBL] [Abstract][Full Text] [Related]
32. Induction of apoptosis in prostate cancer cell lines by the green tea component, (-)-epigallocatechin-3-gallate.
Paschka AG; Butler R; Young CY
Cancer Lett; 1998 Aug; 130(1-2):1-7. PubMed ID: 9751250
[TBL] [Abstract][Full Text] [Related]
33. Gene expression changes induced by green tea polyphenol (-)-epigallocatechin-3-gallate in human bronchial epithelial 21BES cells analyzed by DNA microarray.
Vittal R; Selvanayagam ZE; Sun Y; Hong J; Liu F; Chin KV; Yang CS
Mol Cancer Ther; 2004 Sep; 3(9):1091-9. PubMed ID: 15367703
[TBL] [Abstract][Full Text] [Related]
34. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
35. Lung cancer prevention with (-)-epigallocatechin gallate using monitoring by heterogeneous nuclear ribonucleoprotein B1.
Fujimoto N; Sueoka N; Sueoka E; Okabe S; Suganuma M; Harada M; Fujiki H
Int J Oncol; 2002 Jun; 20(6):1233-9. PubMed ID: 12012004
[TBL] [Abstract][Full Text] [Related]
36. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes.
Ahmed S; Wang N; Lalonde M; Goldberg VM; Haqqi TM
J Pharmacol Exp Ther; 2004 Feb; 308(2):767-73. PubMed ID: 14600251
[TBL] [Abstract][Full Text] [Related]
37. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
Wang YC; Bachrach U
Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
[TBL] [Abstract][Full Text] [Related]
38. In vitro cytotoxicity of (-)-catechin gallate, a minor polyphenol in green tea.
Babich H; Zuckerbraun HL; Weinerman SM
Toxicol Lett; 2007 Jul; 171(3):171-80. PubMed ID: 17606338
[TBL] [Abstract][Full Text] [Related]
39. New TNF-alpha releasing inhibitors as cancer preventive agents from traditional herbal medicine and combination cancer prevention study with EGCG and sulindac or tamoxifen.
Fujiki H; Suganuma M; Kurusu M; Okabe S; Imayoshi Y; Taniguchi S; Yoshida T
Mutat Res; 2003; 523-524():119-25. PubMed ID: 12628509
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of the antigenotoxic potential of monomeric and dimeric flavanols, and black tea polyphenols against heterocyclic amine-induced DNA damage in human lymphocytes using the Comet assay.
Dhawan A; Anderson D; de Pascual-Teresa S; Santos-Buelga C; Clifford MN; Ioannides C
Mutat Res; 2002 Mar; 515(1-2):39-56. PubMed ID: 11909753
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
